← Back to Search

Gaze Tracking Techniques for Baseball Performance

N/A

Waitlist Available

Led By Nick F Fogt

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 60 minutes

Awards & highlights

Study Summary

This trial will study the eye movement of baseball players to see if they can predict where the ball will be thrown.

Who is the study for?

This trial is for individuals with good vision, specifically those who have a stereoacuity of 40 arc seconds or better and 20/20 visual acuity in each eye. It's not suitable for people with lesser stereoacuity or worse than 20/25 visual acuity in either eye.Check my eligibility

What is being tested?

The study measures gaze movements while participants watch videos of baseball pitches to see if there's an anticipatory look towards where the ball will be released. It also checks if experienced players do this more often than inexperienced ones.See study design

What are the potential side effects?

Since this study involves only watching videos and tracking gaze, there are no direct medical side effects associated with the interventions being studied.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 60 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~60 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Quiet eye duration

Trial Design

1Treatment groups

Experimental Treatment

Group I: Gaze trackingExperimental Treatment1 Intervention

No intervention. Monitor gaze as subjects watch a video

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor

827 Previous Clinical Trials

502,730 Total Patients Enrolled

Nick F FogtPrincipal InvestigatorOhio State University

Media Library

Gaze tracking Clinical Trial Eligibility Overview. Trial Name: NCT04289376 — N/A

Gaze Tracking Research Study Groups: Gaze tracking

Gaze Tracking Clinical Trial 2023: Gaze tracking Highlights & Side Effects. Trial Name: NCT04289376 — N/A

Gaze tracking 2023 Treatment Timeline for Medical Study. Trial Name: NCT04289376 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many test subjects have enrolled in the research project?

"Affirmative. The clinical trial, which was first made available on May 5th 2022 and saw its last update on September 23rd 2022 is currently recruiting 20 candidates at a single medical centre; this information can be found on the clinicialtrials.gov website."

Answered by AI

Is the eligibility criteria of this trial inclusive of individuals over age 55?

"The primary parameters for patient enrollment in this trial are a minimum age of 18 and an upper limit of 40 years old."

Answered by AI

What are the criteria for eligibility in this trial?

"This research requires 20 participants in the 18 to 40 age range, with gaze tracking capabilities. Furthermore, they must have normal visual acuity and stereopsis of at least 40 arc seconds or better."

Answered by AI

Is this research study actively seeking participants?

"Affirmative. According to clinicaltrials.gov, this trial was launched on May 5th 2022 and remains open for recruitment as of September 23rd 2022 with a target goal of 20 patients at one medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Quiet Eye Duration in Baseball

Nicklaus Fogt 2022. "Quiet Eye Duration in Baseball". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04289376.